NASC
Nascent Pharma Holdings, Inc.
Set alert
0.01 USD -0.01 -40.00%
0.009 Day range 0.01
0.006 52-week range 0.036
- YTD
- -43.75%
- 1 year
- -55.00%
- Open
- 0.01
- Prev close
- 0.015
- Mkt cap
- 811.95K
- Vol
- 90.00K
- Avg vol
- 44.25K
- EPS
- 0.11
- P/E
- 0.08
More statistics
- Low
- 0.009
- High
- 0.01
Financials — quick view
NASC Revenue — quarterly 7.86M
NASC Net income — quarterly -24.01M
NASC EPS — quarterly -0.48
News
- Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
- Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado
- Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising
- Can B Corp. Secures Lease for 300,000 Square Foot Facility in McMinnville, Tennessee
- Can B Corp. Strengthens Its Vertical Processing Capabilities With Acquisition of Assets From Music City Botanicals
- Can B Corp. Closes Acquisition of Assets from Music City Botanicals to Strengthen its Vertical Processing Capabilities
- Can B Corp. Reports 96% Revenue Growth for Its Second Quarter 2021
- Can B Corp. Closes Acquisition of Assets from TWS Pharma in CO to Significantly Expand Capabilities in Converting Hemp Biomass to Isolate Used in our CBD and Isomer Product Lines
- Can B Corp Announces First Quarter 2021 Results
Your note
Sign in to keep a note on NASC — it syncs with the Stock Master app.